Agenus Inc
(NAS:AGEN)
$
2.81
0.06 (2.18%)
Market Cap: 64.93 Mil
Enterprise Value: 119.07 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 43/100 Agenus Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2023 / 05:00PM GMT
Release Date Price:
$40.8
(+8.51%)
Kelly Shi
Jefferies - Analyst
Thanks for joining Jefferies -- sorry -- Thank you for joining Jefferies New York Healthcare Conference. My name is Kelly Shi, one of the biotech analysts here. And in this session, we are very pleased to have Dr. Garo Armen, Chief Executive Officer, and Zack Armen, IR Director, from Agenus to join this fireside chat session. Welcome.
Zack Armen
Agenus Inc. - Head of IR
Thank you.
Garo Armen
Agenus Inc. - Chairman & CEO
Thank you very much, Kelly.
Kelly Shi
Jefferies - Analyst
Maybe we can start with a company introduction to the audience who are not super familiar with the story and what is your pipeline and what you're focused on at the moment.
Garo Armen
Agenus Inc. - Chairman & CEO
We'll be happy to do. Thank you very much all for attending this session as well and the future attendees via recording.
As some of you know, Agenus was born 29 years ago. And at the time our
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot